Finch Therapeutics Group

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FNCH and other ETFs, options, and stocks.

About FNCH

Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical data to engineer the composition of the microbiome based on disease-modifying mechanisms. 

CEO
Mark Smith
CEOMark Smith
Employees
189
Employees189
Headquarters
Somerville, Massachusetts
HeadquartersSomerville, Massachusetts
Founded
2014
Founded2014
Employees
189
Employees189

FNCH Key Statistics

Market cap
89.18M
Market cap89.18M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
52.72K
Average volume52.72K
High today
$2.00
High today$2.00
Low today
$1.64
Low today$1.64
Open price
$1.77
Open price$1.77
Volume
169.01K
Volume169.01K
52 Week high
$17.39
52 Week high$17.39
52 Week low
$1.58
52 Week low$1.58

FNCH Earnings

-$1.00
-$0.67
-$0.33
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 9, Pre-Market
ActualExpected Nov 9, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.